Pacific Biosciences Of California reported $1.25B in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Accelerate Diagnostics AXDX:US 93.99M 1.32M
Agilent A:US $ 10491M 93M
Bruker BRKR:US $ 3087M 52.1M
Danaher DHR:US $ 78027M 2601M
Fluidigm FLDM:US $ 289.32M 15.88M
General Electric GE:US $ 237559M 7605M
Genmark Diagnostics GNMK:US $ 223.53M 8.94M
Illumina ILMN:US $ 8675M 80M
Luminex LMNX:US $ 819.03M 6.43M
Myriad Genetics MYGN:US $ 1346.5M 9.6M
Nanostring Technologies NSTG:US $ 513.06M 7.5M
Oxford Immunotec Global OXFD:US $ 210.5M 3.89M
Pacific Biosciences Of California PACB:US $ 1245.78M 7.11M
Perkinelmer PKI:US $ 8739.46M 23.26M
Quidel QDEL:US $ 1807.65M 289.72M
Thermo Fisher Scientific TMO:US $ 67698M 1767M
Waters WAT:US $ 3103.65M 107.92M